Mutation Analysis of Epidermal Growth Factor Receptor Gene in Non-Small Cell Lung Cancer for Selection of Patients Eligible for Tyrosine Kinase Inhibitor Therapy

Introduction: Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor therapy is effective as a first-line treatment of advanced non-small-cell lung cancer (NSCLC). This research study investigated the distribution of EGFR mutations in patients diagnosed with NSCLC to assist in selecting...

Full description

Bibliographic Details
Main Authors: Zeeshan Ansar, Asghar Nasir, Tariq Moatter
Format: Article
Language:English
Published: Shaukat Khanum Memorial Trust 2023-12-01
Series:Journal of Cancer and Allied Specialties
Subjects:
Online Access:https://journals.sfu.ca/jcas/index.php/jcas/article/view/569